Ochratoxicosis in Beagle dogs. III. Terminal renal ultrastructural alterations.
D000284:Administration, Oral; D000818:Animals; D001485:Basement Membrane / Q000648:ultrastructure; D003594:Cytoplasmic Granules / Q000648:ultrastructure; D004283:Dog Diseases / Q000139:chemically induced / Q000473:pathology*; D004285:Dogs; D004847:Epithelial Cells; D004848:Epithelium / Q000648:ultrastructure; D006056:Golgi Apparatus / Q000648:ultrastructure; D007668:Kidney / Q000648:ultrastructure*; D007674:Kidney Diseases / Q000139:chemically induced / Q000473:pathology / Q000662:veterinary*; D007686:Kidney Tubules, Distal / Q000648:ultrastructure; D007687:Kidney Tubules, Proximal / Q000648:ultrastructure; D008297:Male; D008928:Mitochondria / Q000648:ultrastructure; D009399:Nephrons / Q000648:ultrastructure; D009793:Ochratoxins / Q000008:administration & dosage / Q000633:toxicity*
D009793:Ochratoxins